.Merck trumps incomes desires, rears purchases outlook on sturdy demand for top drugs like Keytruda CNBCMerck & Co. (MRK US) Trumps Revenue Forecasts as Keytruda Sales Increase BloombergMerck Stock: Pharma Giant Posts Solid Outcomes, However Overview Drops Short Financier's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats revenue and also sales expectations amidst Keytruda strength, however provides combined full-year overview MarketWatch.